Indraprastha Medical Corporation Ltd (INDRAMEDCO) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 131877,
    "name": "Indrapr.Medical",
    "stock_name": "Indrapr.Medical",
    "full_name": "Indraprastha Medical Corporation Ltd",
    "name_url": "stocks-analysis/indraprmedical",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "364.60",
    "chg": 5.45,
    "chgp": "1.52%",
    "dir": 1,
    "prev_price": "359.15",
    "mcapval": "3,380.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532150,
    "symbol": "INDRAMEDCO",
    "ind_name": "Hospital",
    "ind_code": 94,
    "indexname": "India SENSEX",
    "isin": "INE681B01017",
    "curr_date": "May 25",
    "curr_time": "",
    "bse_nse_vol": "5.68 lacs",
    "exc_status": "Active",
    "traded_date": "May 25, 2026",
    "traded_date_str": "2026 05 25",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/indraprmedical-131877-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Indraprastha Medical Corporation Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indraprastha-medical-corporation-ltd-is-rated-sell-4007855",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndraprasthaMed_mojoScore_4007855.png",
        "date": "2026-05-23 10:10:32",
        "description": "Indraprastha Medical Corporation Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 23 May 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Indraprastha Medical Corporation Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indraprastha-medical-corporation-ltd-is-rated-sell-4007835",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndraprasthaMed_mojoScore_4007835.png",
        "date": "2026-05-23 10:10:32",
        "description": "Indraprastha Medical Corporation Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 23 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Indraprastha Medical Corporation Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indraprastha-medical-corporation-ltd-faces-bearish-momentum-amid-technical-downgrade-3997679",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndraprasthaMed_technicaldot_3997679.png",
        "date": "2026-05-19 08:00:25",
        "description": "Indraprastha Medical Corporation Ltd, a small-cap player in the hospital sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. This transition is underscored by a series of technical indicators signalling weakening price momentum, with the stock currently trading at ₹360.05, down 2.15% from its previous close of ₹367.95."
      },
      {
        "title": "Are Indraprastha Medical Corporation Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-indraprastha-medical-corporation-ltd-latest-results-good-or-bad-3989936",
        "imagepath": "",
        "date": "2026-05-13 19:17:01",
        "description": "Indraprastha Medical Corporation Ltd's latest financial results for Q4 FY26 reveal a complex operational landscape. The company reported a net profit of ₹41.70 crores, reflecting a year-on-year growth of 1.68%, which is a notable decline from the previous year's growth rate of 31.57%. Revenue for the quarter reached ₹364.81 crores, marking a year-on-year increase of 9.31%, which is an improvement compared to the 6.04% growth seen in Q4 FY25.\n\nHowever, the results also highlight significant challenges, particularly in terms of operational efficiency. The operating margin, excluding other income, fell to 16.59%, the lowest level in eight quarters, indicating a contraction from 18.37% in the same quarter last year. This margin compression raises concerns about the sustainability of profitability, as it suggests potential issues with cost management or pricing power in a competitive market.\n\nThe company's total..."
      },
      {
        "title": "Indraprastha Medical Q4 FY26: Margin Pressure Weighs on Profitability Despite Revenue Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/indraprastha-medical-q4-fy26-margin-pressure-weighs-on-profitability-despite-revenue-growth-3989570",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndraprasthaMed_quaterlyResult_3989570.png",
        "date": "2026-05-13 10:01:15",
        "description": "Indraprastha Medical Corporation Ltd., the Delhi-based hospital chain operating the flagship Indraprastha Apollo Hospital, reported net profit of ₹41.70 crores for Q4 FY26 (Mar'26), marking a modest sequential growth of 1.71% from ₹41.00 crores in Q3 FY26 (Dec'25), whilst delivering a solid 1.68% year-on-year improvement over ₹41.01 crores in Q4 FY25. With a market capitalisation of ₹3,682 crores, the small-cap hospital operator faces mounting concerns over margin compression and operational efficiency despite maintaining revenue momentum."
      },
      {
        "title": "Indraprastha Medical Corporation Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indraprastha-medical-corporation-ltd-is-rated-sell-3987301",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndraprasthaMed_mojoScore_3987301.png",
        "date": "2026-05-12 10:10:46",
        "description": "Indraprastha Medical Corporation Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Indraprastha Medical Corporation Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indraprastha-medical-corporation-ltd-is-rated-sell-3972066",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/IndraprasthaMed_mojoScore_3972066.png",
        "date": "2026-05-01 10:10:29",
        "description": "Indraprastha Medical Corporation Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Indraprastha Medical Corporation Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indraprastha-medical-corporation-ltd-is-rated-sell-3953799",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndraprasthaMed_mojoScore_3953799.png",
        "date": "2026-04-20 10:10:48",
        "description": "Indraprastha Medical Corporation Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 20 April 2026, providing investors with an up-to-date analysis of the company’s standing."
      },
      {
        "title": "Indraprastha Medical Corporation Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indraprastha-medical-corporation-ltd-is-rated-sell-3939372",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/IndraprasthaMed_mojoScore_3939372.png",
        "date": "2026-04-09 10:10:32",
        "description": "Indraprastha Medical Corporation Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 09 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      }
    ],
    "total": 421,
    "sid": "131877",
    "stock_news_url": "https://www.marketsmojo.com/news/indraprastha-medical-corporation-131877"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "13-May-2026",
      "details": "We hereby submit copies of the public notice of the financial results published on 13th May 2026 in the Financial Express all India editions in English Language and in Jansatta Delhi edition in Hindi language.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for OUTCOME OF THE BOARD MEETING",
      "datetime": "12-May-2026",
      "details": "the board of directors of the company inter-alia : 1. Approved the audited finacial results for the quater/year ended 31st March 2026 2. Reccomended a dividend @ 40% i.e. Rs 4 per equity shares for the finacial year 2025-2026 subject to approval of shareholders at the AGM of the company.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Audited Financial Results And Dividend",
      "datetime": "01-May-2026",
      "details": "Indraprastha Medical Corporation Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/05/2026 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 it is hereby informed that a meeting of the Board of Directors of the Company will be held on Tuesday 12th May 2026 inter alia: - a) to consider and approve the audited financial results for the quarter/ year ended 31st March 2026; and b) to consider and recommend dividend if any on equity shares of the Company for the financial year 2025-26. This is for your information and record.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Indraprastha Medical Corporation Ltd has declared <strong>45%</strong> dividend, ex-date: 18 Sep 25",
          "dt": "2025-09-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Indraprastha Medical Corporation Ltd is Rated Sell

2026-05-23 10:10:32

Indraprastha Medical Corporation Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 23 May 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Indraprastha Medical Corporation Ltd is Rated Sell

2026-05-23 10:10:32

Indraprastha Medical Corporation Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 23 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Indraprastha Medical Corporation Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-05-19 08:00:25

Indraprastha Medical Corporation Ltd, a small-cap player in the hospital sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. This transition is underscored by a series of technical indicators signalling weakening price momentum, with the stock currently trading at ₹360.05, down 2.15% from its previous close of ₹367.95.

Read full news article

Are Indraprastha Medical Corporation Ltd latest results good or bad?

2026-05-13 19:17:01

Indraprastha Medical Corporation Ltd's latest financial results for Q4 FY26 reveal a complex operational landscape. The company reported a net profit of ₹41.70 crores, reflecting a year-on-year growth of 1.68%, which is a notable decline from the previous year's growth rate of 31.57%. Revenue for the quarter reached ₹364.81 crores, marking a year-on-year increase of 9.31%, which is an improvement compared to the 6.04% growth seen in Q4 FY25. However, the results also highlight significant challenges, particularly in terms of operational efficiency. The operating margin, excluding other income, fell to 16.59%, the lowest level in eight quarters, indicating a contraction from 18.37% in the same quarter last year. This margin compression raises concerns about the sustainability of profitability, as it suggests potential issues with cost management or pricing power in a competitive market. The company's total...

Read full news article

Indraprastha Medical Q4 FY26: Margin Pressure Weighs on Profitability Despite Revenue Growth

2026-05-13 10:01:15

Indraprastha Medical Corporation Ltd., the Delhi-based hospital chain operating the flagship Indraprastha Apollo Hospital, reported net profit of ₹41.70 crores for Q4 FY26 (Mar'26), marking a modest sequential growth of 1.71% from ₹41.00 crores in Q3 FY26 (Dec'25), whilst delivering a solid 1.68% year-on-year improvement over ₹41.01 crores in Q4 FY25. With a market capitalisation of ₹3,682 crores, the small-cap hospital operator faces mounting concerns over margin compression and operational efficiency despite maintaining revenue momentum.

Read full news article

Indraprastha Medical Corporation Ltd is Rated Sell

2026-05-12 10:10:46

Indraprastha Medical Corporation Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 May 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Indraprastha Medical Corporation Ltd is Rated Sell

2026-05-01 10:10:29

Indraprastha Medical Corporation Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Indraprastha Medical Corporation Ltd is Rated Sell

2026-04-20 10:10:48

Indraprastha Medical Corporation Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 20 April 2026, providing investors with an up-to-date analysis of the company’s standing.

Read full news article

Indraprastha Medical Corporation Ltd is Rated Sell

2026-04-09 10:10:32

Indraprastha Medical Corporation Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 January 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 09 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

View All News